Chartwell Investment Partners, LLC Atara Biotherapeutics, Inc. Transaction History

Chartwell Investment Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 11, 2019	SELL	$28.4 - $41.74 $963,356 - $1.42 Million	-33,921 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$30.9 - $42.97 $32,506 - $45,204	1,052 Added 3.2%	33,921 $1.18 Million
Q3 2018 Nov 08, 2018	BUY	$35.05 - $43.5 $1,612 - $2,001	46 Added 0.14%	32,869 $1.36 Million
Q2 2018 Aug 09, 2018	BUY	$35.15 - $51.45 $1.15 Million - $1.69 Million	32,823 New	32,823 $1.21 Million
Q1 2018 May 08, 2018	SELL	$18.0 - $48.35 $663,606 - $1.78 Million	-36,867 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$18.0 - $48.35 $663,606 - $1.78 Million	36,867 New	36,867 $1.44 Million

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $582M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.